These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 29865040)
1. The prognostic value of preoperative inflammatory indexes in gallbladder carcinoma with hepatic involvement. Tao Z; Li SX; Cui X; Huang Y; Zhu S; Wang Y; Tan H; Ma X Cancer Biomark; 2018; 22(3):551-557. PubMed ID: 29865040 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma. Zhang Y; Jiang C; Li J; Sun J; Qu X Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119 [TBL] [Abstract][Full Text] [Related]
3. Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma. Pang Q; Zhang LQ; Wang RT; Bi JB; Zhang JY; Qu K; Liu SS; Song SD; Xu XS; Wang ZX; Liu C World J Gastroenterol; 2015 Jun; 21(21):6675-83. PubMed ID: 26074706 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma. Zhang L; Wang R; Chen W; Xu X; Dong S; Fan H; Liu C HPB (Oxford); 2016 Jul; 18(7):600-7. PubMed ID: 27346141 [TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes and prognostic markers in gallbladder cancer. Cui X; Zhu S; Tao Z; Deng X; Wang Y; Gao Y; Liao Y; Ma W; Zhang Y; Ma X Medicine (Baltimore); 2018 Jul; 97(28):e11396. PubMed ID: 29995783 [TBL] [Abstract][Full Text] [Related]
6. [Effect of preoperative monocyte-lymphocyte ratio on prognosis of patients with resectable esophagogastric junction cancer]. Zhou WJ; Wu J; Li XD; Wang Q; Ni XF; Jiang JT; Ji M; Wu CP Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):178-183. PubMed ID: 28316215 [No Abstract] [Full Text] [Related]
7. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Deng M; Ma X; Liang X; Zhu C; Wang M Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461 [TBL] [Abstract][Full Text] [Related]
8. A High Monocyte-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Advanced Gallbladder Cancer Receiving Chemotherapy. Choi YH; Lee JW; Lee SH; Choi JH; Kang J; Lee BS; Paik WH; Ryu JK; Kim YT Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1045-1051. PubMed ID: 30842131 [TBL] [Abstract][Full Text] [Related]
9. Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival. Cummings M; Merone L; Keeble C; Burland L; Grzelinski M; Sutton K; Begum N; Thacoor A; Green B; Sarveswaran J; Hutson R; Orsi NM Br J Cancer; 2015 Jul; 113(2):311-20. PubMed ID: 26079303 [TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of combining preoperative serum tumor markers and peripheral blood routine indexes in patients with colorectal cancer]. Huang L; Fang J; Wu J; Zhou X; Wei H Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1421-1426. PubMed ID: 30588596 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection. Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390 [TBL] [Abstract][Full Text] [Related]
12. Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma. Shi L; Qin X; Wang H; Xia Y; Li Y; Chen X; Shang L; Tai YT; Feng X; Acharya P; Acharya C; Xu Y; Deng S; Hao M; Zou D; Zhao Y; Ru K; Qiu L; An G Oncotarget; 2017 Mar; 8(12):18792-18801. PubMed ID: 27852046 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients. Hu H; Yao X; Xie X; Wu X; Zheng C; Xia W; Ma S World J Urol; 2017 Feb; 35(2):261-270. PubMed ID: 27255479 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of pre-operative neutrophil/lymphocyte ratio, monocyte count, mean platelet volume, and platelet/lymphocyte ratio in endometrial cancer. Temur I; Kucukgoz Gulec U; Paydas S; Guzel AB; Sucu M; Vardar MA Eur J Obstet Gynecol Reprod Biol; 2018 Jul; 226():25-29. PubMed ID: 29804024 [TBL] [Abstract][Full Text] [Related]
15. The Prognostic Value of Inflammation Factors in Hepatocellular Carcinoma Patients with Hepatic Artery Interventional Treatments: A Retrospective Study. Guo L; Ren H; Pu L; Zhu X; Liu Y; Ma X Cancer Manag Res; 2020; 12():7173-7188. PubMed ID: 33061563 [TBL] [Abstract][Full Text] [Related]
16. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer. Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313 [TBL] [Abstract][Full Text] [Related]
17. Preoperative Hematologic Inflammatory Markers as Prognostic Factors in Patients with Glioma. Bao Y; Yang M; Jin C; Hou S; Shi B; Shi J; Lin N World Neurosurg; 2018 Nov; 119():e710-e716. PubMed ID: 30092479 [TBL] [Abstract][Full Text] [Related]
18. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation? Solmaz Medeni S; Acar C; Olgun A; Acar A; Seyhanlı A; Taskıran E; Sevindik OG; Alacacıoglu I; Piskin O; Ozcan MA; Demirkan F; Undar B; Ozsan GH Clin Transplant; 2018 Sep; 32(9):e13359. PubMed ID: 30053318 [TBL] [Abstract][Full Text] [Related]
19. Correlation of Prognostic Markers {CEA, Ca19.9, Neutrophil To Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR)} With Progression Free Survival (PFS) in Advanced/Metastatic Gallbladder Carcinoma. Naik MD; Kataria SP; Kumar G; Singh R J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443542 [TBL] [Abstract][Full Text] [Related]
20. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]